Key facts
- · Type: New offering first sale 2026-09-17 · Amount sold: $550K · Total offering: $20M · SEC filing
- · Type: Amendment first sale 2023-02-09 · Amount sold: $10.02M · Total offering: $20M · SEC filing
- · Type: Amendment first sale 2023-02-09 · Amount sold: $5.22M · Total offering: $10M · SEC filing
- · Type: Amendment first sale 2023-02-09 · Amount sold: $1.86M · Total offering: $10M · SEC filing
- · Type: New offering first sale 2023-02-09 · Amount sold: $430K · Total offering: $10M · SEC filing
Plymouth, MINNESOTA
Biotechnology
5
$980K
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-23 | New offering first sale 2026-09-17 | $550K | $20M | details · SEC filing |
| 2025-08-21 | Amendment first sale 2023-02-09 | $10.02M | $20M | SEC filing |
| 2024-07-29 | Amendment first sale 2023-02-09 | $5.22M | $10M | SEC filing |
| 2023-07-31 | Amendment first sale 2023-02-09 | $1.86M | $10M | SEC filing |
| 2023-04-14 | New offering first sale 2023-02-09 | $430K | $10M | SEC filing |
Keep reading
More on Medical 21, Inc. and the records around it.
Medical 21, Inc. elsewhere on the record
- Form D filing Oct 2026
- IPO filing Mar 2026
Watch Medical 21, Inc.
Get an email when Medical 21, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Medical 21, Inc.?
Who to contact
- Manny Villafana — Executive Officer, Director
- Eric Solien — Executive Officer
- Jeff Vreeman — Executive Officer
- Andrea Sweeney — Executive Officer
- Round: Form D filed 2026-10-23
- Amount sold: $550K
- Industry: Biotechnology
- Based: Plymouth, MINNESOTA
People listed
- Manny Villafana — Executive Officer, Director
- Eric Solien — Executive Officer
- Jeff Vreeman — Executive Officer
- Andrea Sweeney — Executive Officer
- Filing: Form D filed 2026-10-23
- Amount sold: $550K
- Industry group: Biotechnology
- Based: Plymouth, MINNESOTA
- Entity type: Corporation
We'll show it in your MentionFox inbox when Medical 21, Inc. raises, hires or launches. No email unless you switch it on.
Watch Medical 21, Inc. →Want the whole picture on Medical 21, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Medical 21, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medical 21, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Medical 21, Inc.'s own filings with the SEC. The people those filings name are on the team page.